logoTry Persana

Benchling - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Benchling including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Benchling company logo

Unlocking the power of biotechnology through modern software.

Benchling is a biotechnology company specializing in R&D cloud software, aiming to transform research processes and accelerate product discovery in the life sciences.

HeadquartersSan Francisco, California, United States
Team size500-1000
Founded2012

What is Benchling? - Company Overview & Details

Benchling is Benchling is a biotechnology company specializing in R&D cloud software, aiming to transform research processes and accelerate product discovery in the life sciences. Founded in 2012, the company is headquartered in San Francisco, California, United States.

Who Founded Benchling?

Benchling was founded by Sajith Wickramasekara.

Who are the Key Executives at Benchling? - Leadership Team

Benchling is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Benchling

Sajith WickramasekaraCEO

Chief Technology Officer (CTO) of Benchling

Stephen DeasyCTO

About Sajith Wickramasekara - CEO of Benchling

Sajith Wickramasekara serves as the Chief Executive Officer of Benchling, leading the company's strategic vision and operations. Connect with them on LinkedIn for professional insights.

Benchling Company Details & Key Information

Where is Benchling located?

Benchling is headquartered in San Francisco, California, United States.

How many employees does Benchling have?

Benchling has 500-1000 employees.

When was Benchling founded?

Benchling was founded in 2012.

Benchling Official Website

How much funding has Benchling raised?

Benchling has raised $600 Million across 9 funding rounds. The most recent funding was completed on 2021-12-17.

Funding Overview

Benchling has raised a total of $600 million across several funding rounds, with the latest being a $100 million Series F round.

$600 Million
Total Funding Raised
9
Funding Rounds
2021-12-17
Latest Round

Benchling Funding History

Series F
2021-12-17
$100 Million$6.1 Billion valuation

Who are the key investors in Benchling?

Benchling is backed by 2 key investors including Altimeter Capital, Franklin Templeton. These investors focus on sectors.

Benchling Investor Overview

2
Key Investors
0
Focus Areas
0
Notable Investments

Complete List of Benchling Investors

Altimeter Capital

Franklin Templeton

What sectors do Benchling investors focus on?

The investors backing Benchling primarily focus on sectors.

Featured Investor: Altimeter Capital

Altimeter Capital

Notable Investments:

What are Benchling's future plans?

Benchling Expand product capabilities and enhance biotechnology R&D tools.

Benchling Strategic Outlook

Strategic Focus
Defined
1
Key Challenges
1
Growth Opportunities

What challenges does Benchling face?

Benchling has identified 1 key challenges that need to be addressed for continued growth and success.

Key Challenges for Benchling

1

Adapting to rapid changes in biotech research needs.

What opportunities does Benchling have?

Benchling has identified 1 key opportunities for growth and market expansion.

Growth Opportunities for Benchling

1

Growing demand for biotech solutions.

Benchling Strategic Position Summary

Key Focus Areas

Benchling is addressing 1 strategic challenges to strengthen its market position.

Growth Potential

The company has identified 1 key opportunities for expansion and growth.

What are the latest news about Benchling?

Benchling has 2 recent news updates covering key business developments and market activities.

Benchling News Overview

2
Recent Articles
Active
Media Coverage
2025-05-07
Latest Update

What is Benchling in the news for?

Benchling is currently featured in news for Benchling partnered with Moderna Therapeutics Inc. on May 7th '25. and other significant business developments.

Recent News Articles About Benchling

Article 1
2025-05-07

Benchling partnered with Moderna Therapeutics Inc. on May 7th '25.

Benchling announced an expanded collaboration with Moderna, enhancing AI-driven research capabilities.

manilatimes.net
Read News
Article 2
2024-10-22

Benchling acquires Pipebio.

Benchling acquired PipeBio to enhance its bioinformatics and cloud software capabilities for biologics research.

arcticstartup.com
Read News

Benchling FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Benchling including information about founders, CEO, funding history, investors, headquarters location, and company details. 19 frequently asked questions covering key information about the company.

Benchling Questions & Answers - Company Information

Q1

What is Benchling?

Benchling is a biotechnology company specializing in R&D cloud software, aiming to transform research processes and accelerate product discovery in the life sciences.

Q2

Who founded Benchling?

Benchling was founded by Sajith Wickramasekara.

Q3

Who is the CEO of Benchling?

The CEO of Benchling is Sajith Wickramasekara. You can find more information about them on their LinkedIn profile.

Q4

How much funding has Benchling raised?

Benchling has raised a total of $$600 Million across 9 funding rounds. The most recent funding was completed on 2021-12-17.

Q5

Who are the investors in Benchling?

Benchling's key investors include Altimeter Capital, Franklin Templeton.

Q6

Where is Benchling headquartered?

Benchling is headquartered in San Francisco, California, United States.

Q7

When was Benchling founded?

Benchling was founded in 2012.

Q8

How many employees does Benchling have?

Benchling has 500-1000 employees.

Q9

What is Benchling's official website?

You can visit Benchling's official website at https://benchling.com.

Q10

What was Benchling's latest funding round?

Benchling's latest funding round was a Series F round of $$100 Million completed on 2021-12-17.

Q11

Who is founder?

Sajith Wickramasekara

Q12

Who is cto?

Stephen Deasy

Q13

What does the company do?

Benchling specializes in R&D cloud software for biotechnology, aiming to enhance research processes and accelerate product discovery.

Q14

How much funding?

$600 Million

Q15

Latest funding date?

2021-12-17

Q16

Who are the investors?

Altimeter Capital Franklin Templeton

Q17

What are the challenges?

Adapting to rapid changes in biotech research needs.

Q18

What are the opportunities?

Growing demand for biotech solutions.

Q19

Latest news?

Benchling announced an expanded collaboration with Moderna, enhancing AI-driven research capabilities. Benchling acquired PipeBio to enhance its bioinformatics and cloud software capabilities for biologics research.

More Information About Benchling

For additional details about Benchling, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.